Locations
England, UK · Oxford, UK
industry
Biotechnology · DeepTech
Size
11-50 employees
Stage
Other
founded in
2020
Dark Blue Therapeutics is an innovative drug discovery biotechnology company based in Oxford, UK, focused on pioneering the next generation of precision oncology medicines. The company leverages unique partnerships with world-leading academic experts to exploit groundbreaking insights on novel cancer dependencies, coupled with cutting-edge discovery science to deliver highly tuned transformational precision medicines for patients with the highest unmet medical needs. Their pipeline includes first-in-class drugs with transformative potential, and they are agnostic of cancer mechanisms, applying various chemical drug modes of action to work on the most attractive targets. Dark Blue Therapeutics aims to match their precision medicines to molecularly defined patient populations, addressing critical unmet patient needs and transforming outcomes for cancer patients.
Something looks off?